CINRYZE
CINRYZE
Dormant
DIN Number
02395371
Drug Class
Human
Market Date
Mar 8, 2016
Company
HC
takeda canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02395371
AIG Number0152746001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B06AC01 C1-INHIBITOR, PLASMA DERIVED
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification92:32.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
C1 ESTERASE INHIBITOR (HUMAN)Active
Strength: 500 UNIT / VIAL
Monograph: C1 ESTERASE INHIBITOR (HUMAN)